Syndopa 275 mg Sun Pharmaceuticals Industries
€8.00
| Water Retention |
Minimal to none |
|---|---|
| Hepatotoxicity |
Low to none |
| Lab Test |
Monitoring of liver and kidney functions may be recommended |
| Strength |
275 mg |
| Also known as |
L-DOPA |
| Blood pressure |
Can cause orthostatic hypotension |
| Trade name |
Sinemet, Levodopa, Dopar |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Chemical name |
L-3,4-dihydroxyphenylalanine |
| Formula |
C9H11NO4 |
| Substance class |
Amino acid derivative |
| Main action |
Precursor to dopamine, used to increase dopamine concentrations in the treatment of Parkinson's disease and dopamine-responsive dystonia |
| Half-life |
1 to 3 hours |
| Dosage (medical) |
Typically, initial doses are 100 mg daily, increasing gradually as needed and tolerated. Maintenance doses usually range from 300 mg to 800 mg per day, divided into multiple doses |
| Dosage (sports) |
Not applicable as it is not used for enhancing sports performance |
| Effects |
Improves motor control and reduces symptoms of Parkinson's disease |
| Side effects |
Nausea, vomiting, hypotension, dyskinesias, hallucinations, dizziness, and confusion |
| Use in sports |
Not typically used in sports, considered doping if used to enhance performance |
| Manufacturer |
Sun Pharmaceuticals Industries |
Reviews
There are no reviews yet.